Anticoagulation in the Elderly
AbstractManagement of anticoagulation in elderly patients represents a particularly challenging issue. Indeed, this patient population is at high thromboembolic risk, but also at high hemorrhagic risk. Assessment of the benefit-risk balance of anticoagulation is the key point when decisions are made about introducing and/or continuing such treatments in the individual elderly patient. In order to maximise the safety of anticoagulation in the elderly, some specific considerations need to be taken into account, including renal insufficiency, modified pharmacodynamics of anticoagulants, especially vitamin K antagonists, and the presence of multiple comorbidities and concomitant medications. New anticoagulants could greatly simplify and possibly increase the safety of anticoagulation in the elderly in the near future. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Robert-Ebadi, H.; Righini, M. Anticoagulation in the Elderly. Pharmaceuticals 2010, 3, 3543-3569.
Robert-Ebadi H, Righini M. Anticoagulation in the Elderly. Pharmaceuticals. 2010; 3(12):3543-3569.Chicago/Turabian Style
Robert-Ebadi, Helia; Righini, Marc. 2010. "Anticoagulation in the Elderly." Pharmaceuticals 3, no. 12: 3543-3569.